Free Trial

Repare Therapeutics (RPTX) Competitors

Repare Therapeutics logo
$1.32 0.00 (0.00%)
As of 02:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RPTX vs. PROK, FHTX, RZLT, ANNX, NVCT, AARD, MNPR, DRUG, SLRN, and OCGN

Should you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include ProKidney (PROK), Foghorn Therapeutics (FHTX), Rezolute (RZLT), Annexon (ANNX), Nuvectis Pharma (NVCT), Aardvark Therapeutics (AARD), Monopar Therapeutics (MNPR), Bright Minds Biosciences (DRUG), Acelyrin (SLRN), and Ocugen (OCGN). These companies are all part of the "pharmaceutical products" industry.

Repare Therapeutics vs.

Repare Therapeutics (NASDAQ:RPTX) and ProKidney (NASDAQ:PROK) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, community ranking, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Repare Therapeutics has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, ProKidney has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500.

Repare Therapeutics currently has a consensus target price of $4.50, indicating a potential upside of 240.91%. ProKidney has a consensus target price of $5.00, indicating a potential upside of 616.33%. Given ProKidney's higher possible upside, analysts clearly believe ProKidney is more favorable than Repare Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Repare Therapeutics
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
ProKidney
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

ProKidney has lower revenue, but higher earnings than Repare Therapeutics. ProKidney is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Repare Therapeutics$53.48M1.06-$93.80M-$3.01-0.44
ProKidney$306K667.66-$35.47M-$0.60-1.16

In the previous week, Repare Therapeutics' average media sentiment score of 1.73 beat ProKidney's score of -0.64 indicating that Repare Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Repare Therapeutics Very Positive
ProKidney Negative

85.1% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 51.6% of ProKidney shares are owned by institutional investors. 11.5% of Repare Therapeutics shares are owned by company insiders. Comparatively, 41.5% of ProKidney shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Repare Therapeutics received 35 more outperform votes than ProKidney when rated by MarketBeat users. Likewise, 64.18% of users gave Repare Therapeutics an outperform vote while only 53.33% of users gave ProKidney an outperform vote.

CompanyUnderperformOutperform
Repare TherapeuticsOutperform Votes
43
64.18%
Underperform Votes
24
35.82%
ProKidneyOutperform Votes
8
53.33%
Underperform Votes
7
46.67%

ProKidney has a net margin of 0.00% compared to Repare Therapeutics' net margin of -99.76%. ProKidney's return on equity of 0.00% beat Repare Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Repare Therapeutics-99.76% -40.87% -35.07%
ProKidney N/A N/A -10.24%

Summary

ProKidney beats Repare Therapeutics on 9 of the 15 factors compared between the two stocks.

Get Repare Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPTX vs. The Competition

MetricRepare TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$56.62M$6.49B$5.33B$8.35B
Dividend YieldN/A2.64%5.20%4.10%
P/E Ratio-0.668.5626.7419.65
Price / Sales1.06258.46394.49119.78
Price / CashN/A65.8538.3234.62
Price / Book0.266.406.744.50
Net Income-$93.80M$143.98M$3.23B$248.32M
7 Day Performance-1.49%0.06%0.13%-0.96%
1 Month Performance3.13%1.81%8.83%10.86%
1 Year Performance-57.42%-0.92%18.45%9.08%

Repare Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPTX
Repare Therapeutics
3.0721 of 5 stars
$1.32
flat
$4.50
+240.9%
-60.0%$56.62M$53.48M-0.66180Positive News
PROK
ProKidney
1.8023 of 5 stars
$0.81
+0.2%
$5.00
+518.5%
-79.6%$236.62M$76,000.00-1.473Analyst Upgrade
FHTX
Foghorn Therapeutics
2.4844 of 5 stars
$4.21
-5.0%
$12.13
+188.0%
-33.4%$234.67M$22.60M-2.19120Gap Down
RZLT
Rezolute
2.6295 of 5 stars
$3.80
+6.4%
$12.14
+219.5%
+38.8%$230.03MN/A-3.1140Analyst Downgrade
ANNX
Annexon
1.855 of 5 stars
$2.09
+4.0%
$12.50
+498.1%
-57.8%$229.30MN/A-1.9960Gap Down
NVCT
Nuvectis Pharma
2.2004 of 5 stars
$10.95
+10.9%
$17.00
+55.3%
+49.2%$228.79MN/A-9.448
AARD
Aardvark Therapeutics
N/A$10.43
+5.5%
$31.25
+199.6%
N/A$226.29MN/A0.0018Analyst Downgrade
MNPR
Monopar Therapeutics
2.8903 of 5 stars
$36.90
-0.7%
$55.33
+50.0%
+1,053.3%$225.64MN/A-18.7310News Coverage
Positive News
Analyst Upgrade
Gap Down
DRUG
Bright Minds Biosciences
3.0163 of 5 stars
$31.99
-3.1%
$83.25
+160.2%
+2,574.3%$225.34MN/A-188.17N/ANews Coverage
Positive News
Analyst Forecast
SLRN
Acelyrin
3.4778 of 5 stars
$2.23
-0.9%
$9.60
+330.5%
N/A$225.13MN/A-0.91135Positive News
OCGN
Ocugen
1.1897 of 5 stars
$0.77
+1.5%
$6.00
+679.4%
-46.9%$224.81M$4.52M-4.2880Positive News

Related Companies and Tools


This page (NASDAQ:RPTX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners